Valeo Pharma Inc. ( VPHIF) - Key Metrics
VPHIF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | $0.13 | -$0.08 | $0 | $0 |
| 2024Q2 | $0.14 | -$0.08 | -$0.04 | -$0.04 |
| 2024Q1 | $0.16 | -$0.08 | $0.02 | $0.02 |
| 2023Q4 | $0.14 | -$0.10 | -$0.03 | -$0.08 |
| 2023Q3 | $0.17 | -$0.07 | -$0.01 | -$0.02 |
VPHIF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | 0% | -0.16 |
| 2024Q2 | 0% | -0.15 |
| 2024Q1 | 0% | -1.04 |
| 2023Q4 | 0% | -0.37 |
| 2023Q3 | 0% | -1.57 |
VPHIF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2024Q3 | 8.80% | 0% |
| 2024Q2 | -76.53% | 0% |
| 2024Q1 | 4.98% | 0% |
| 2023Q4 | -56.27% | 0% |
| 2023Q3 | -3.73% | 0% |
VPHIF
Price: $0
52 week price:
Earnings Per Share: -0.27 USD
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 9866